Pancreatic Cancer Research

ResearcherHospital Universitario Ramón y CajalNo recent work listed

Carmen Guillén

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 6 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers
0
Trials
2 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2013: 1 trial · 2014: none · 2015: 1 trial

Trials 2

  1. Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma Study chair NCT02504333↗
  2. Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer Principal investigator NCT02382263↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alfredo Carrato · 1 shared trial, 2015 · strength 0.16
  2. Adelaida La Casta · 1 shared trial, 2013 · strength 0.05
  3. José I Martín · 1 shared trial, 2013 · strength 0.05
  4. Manuel Hidalgo · 1 shared trial, 2013 · strength 0.05
  5. Javier Sastre · 1 shared trial, 2013 · strength 0.05
  6. Fernando Rivera · 1 shared trial, 2013 · strength 0.05
  7. Teresa Macarulla · 1 shared trial, 2013 · strength 0.05
  8. Roberto Pazo · 1 shared trial, 2013 · strength 0.05
  9. Rut Vera · 1 shared trial, 2013 · strength 0.05
  10. Inmaculada Alés · 1 shared trial, 2013 · strength 0.05
  11. Rafael López · 1 shared trial, 2013 · strength 0.05
  12. Joaquina Martínez · 1 shared trial, 2013 · strength 0.05
  13. Manuel Valladares · 1 shared trial, 2013 · strength 0.05
  14. Andrés Muñoz · 1 shared trial, 2013 · strength 0.05
  15. Roberto P Díaz · 1 shared trial, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.